PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
03-Sep-2020 UK Medicines and Healthcare Products Regulatory Agency issues an Early Access to Medicines Scheme positive scientific opinion for Avelumab as First-Line Maintenance Treatment for patients with Locally Advanced or Metastatic Urothelial Carcinoma Merck
03-Sep-2020 Ionis to present at upcoming virtual investor conferences Ionis Pharmaceuticals, Inc.
03-Sep-2020 Compugen to Present at Upcoming September 2020 Investor Conferences Compugen Ltd.
03-Sep-2020 Akebia Therapeutics Announces Top-Line Results from its PRO2TECT Global Phase 3 Program of Vadadustat for Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients Not on Dialysis Akebia Therapeutics
03-Sep-2020 Late-breaking Libtayo® (cemiplimab) pivotal data in advanced non-small cell lung cancer and basal cell carcinoma to be presented at ESMO Sanofi
03-Sep-2020 Phosplatin Therapeutics Announces Oral Presentation of Phase 1b Combination Study of PT-112 Plus Avelumab at ESMO Virtual Congress 2020 Phosplatin Therapeutics
03-Sep-2020 Late-breaking Libtayo® (cemiplimab) Pivotal Data in Advanced Non-small Cell Lung Cancer and Basal Cell Carcinoma to Be Presented at ESMO Regeneron Pharmaceuticals, Inc.
03-Sep-2020 Registration is now open for the Pre-filled Syringes and Injectable devices Conference 2021 SMi Group
03-Sep-2020 Dutch Amarna Therapeutics Announces the Appointment of Steen Klysner as Chief Executive Officer B3C newswire
03-Sep-2020 Polyphor announces financial results for the first half 2020 Polyphor AG
03-Sep-2020 Biotest AG: Biotest phase II study for the treatment of severe COVID-19 patients with trimodulin approved Biotest AG
02-Sep-2020 Siemens Healthineers AG: Siemens Healthineers determines the placement price for the new shares from the capital increase Siemens Healthineers AG
02-Sep-2020 ABIVAX: Abivax reports long-lasting two-year efficacy and safety data from ABX464 ulcerative colitis Phase 2a maintenance study ABIVAX
02-Sep-2020 Gilead Sciences and Jounce Therapeutics Announce Exclusive License Agreement for Novel Immunotherapy Program Gilead Sciences, Jounce Therapeutics
02-Sep-2020 Siemens Healthineers AG: Siemens Healthineers launches cash capital increase with exclusion of shareholders' subscription rights through accelerated bookbuilding Siemens Healthineers AG
02-Sep-2020 Almac Group Donates a Quarter of a Million Pounds to Global Charities in Wake of COVID-19 Almac Group
02-Sep-2020 Nass Valley Gateway LTD. Redesigns Brand And Packaging to Reflect New Line of Premium CBD Products Nass Valley Gateway Ltd.
02-Sep-2020 4Front Ventures Granted Final State Approval for Adult-Use Cannabis Sales at its Mission Facilities in Worcester, Massachusetts with a Grand Opening slated for September 9, 2020 4Front
02-Sep-2020 MPH Health Care AG: 1st half of 2020 MPH Health Care AG
02-Sep-2020 Daiichi Sankyo moves into new UK HQ in Uxbridge Business Park Daiichi Sankyo